<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01009996</url>
  </required_header>
  <id_info>
    <org_study_id>SMG-003</org_study_id>
    <nct_id>NCT01009996</nct_id>
  </id_info>
  <brief_title>Efficacy Study of Kissing Drug‐Eluting Balloons in Coronary Bifurcation Lesions</brief_title>
  <acronym>KISSING DEBBIE</acronym>
  <official_title>Kissing Drug‐Eluting Balloons After Bare Metal Stenting of Coronary Bifurcation Lesions.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ospedale Santa Maria Goretti</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ospedale Santa Maria Goretti</source>
  <brief_summary>
    <textblock>
      KISSING DEBBIE's aim at assessing angiographic and clinical outcomes of provisional treatment
      of coronary bifurca6on lesions according to TAP sten6ng with BMS and final kissing DEB
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Funding issues
  </why_stopped>
  <start_date type="Anticipated">October 2009</start_date>
  <completion_date type="Anticipated">April 2011</completion_date>
  <primary_completion_date type="Anticipated">February 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Late lumen loss on both MV and SB</measure>
    <time_frame>9 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Procedural success (residual stenosis &lt;20% on MV and &lt;50% on SB with TIMI flow 3 for both)</measure>
    <time_frame>immediate</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Binary restenosis rate</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major adverse cardiac events</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major adverse cardiac events</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major adverse cardiac events</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major adverse cardiac events</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">0</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Bifurcation Lesions</condition>
  <arm_group>
    <arm_group_label>Coronary bifurcation lesions</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Kissing DEB</intervention_name>
    <description>Provisional bare metal stenting followed by kissing drug-eluting balloons</description>
    <arm_group_label>Coronary bifurcation lesions</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All coming
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;18 years

          -  De novo major bifurca6on lesion of the left coronary artery (LAD‐D; LCX-OM)

          -  RVD 2.25‐4.0 mm

        Exclusion Criteria:

          -  LMCA

          -  AMI within 48 hours

          -  Limited compliance with 3-month dual antiplatelet therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>UOC Emodinamica e Cardiologia Interventistica - Ospedale Santa Maria Goretti</name>
      <address>
        <city>Latina</city>
        <zip>04100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>November 6, 2009</study_first_submitted>
  <study_first_submitted_qc>November 6, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 9, 2009</study_first_posted>
  <last_update_submitted>February 21, 2020</last_update_submitted>
  <last_update_submitted_qc>February 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ospedale Santa Maria Goretti</investigator_affiliation>
    <investigator_full_name>Gregory Sgueglia, MD</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Coronary bifurcation lesions</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

